Advertisement

The Clinical Relevance of Bone Mass Measurements

  • I. Fogelman
  • A. Rodin

Abstract

Osteoporosis can be defined as a reduction in the amount of bone mass per unit volume throughout the skeleton. It is associated with an increased susceptibility to fracture and this may occur without trauma. Osteoporosis is a disease which primarily affects the elderly, and women are more often affected than men. Bone loss is a universal phenomenon which occurs with aging, however, in women there is thought to be an acceleration in the rate of bone loss following the menopause [1, 2]. Why this should occur is not fully understood, but it is most likely due to the withdrawal of a protective effect of oestrogen against bone resorption [3, 4]. There is no doubt that osteoporosis is a massive health care problem associated with high morbidity and significant mortality. Indeed, it has been described as the commonest of all diseases [5] and it has been estimated that in the United States between 15 to 20 million people are affected. Osteoporosis is the underlying cause of about 1.3 million new fractures per year in those over the age of 45 [6]. As the life expectancy of the population increases, the prevalence of osteoporosis will inevitably continue to rise.

Keywords

Bone Loss Bone Mass Anorexia Nervosa Bone Mineral Content Bone Mass Measurement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heaney, RP, Recker, RR and Saville, PD (1978). Menopausal changes in bone remodelling. J Lab Clin Med, 92, 964PubMedGoogle Scholar
  2. 2.
    Cann, CE, Gennant, HK, Ettinger, B and Gordon, GS (1980). Spinal mineral loss in oophorectomized women. JAMA, 244, 2056PubMedCrossRefGoogle Scholar
  3. 3.
    Lindsay, R, Aitken, JM, Anderson, JB, Hart, DM, MacDonald, EB and Clarke, AC (1976). Long term prevention of post-menopausal osteoporosis by oestrogen. Lancet, 1, 1038PubMedCrossRefGoogle Scholar
  4. 4.
    Heaney, RP, Recker, RR and Saville, PD (1978). Menopausal changes in calcium balance performance. J Lab Clin Med, 92, 953PubMedGoogle Scholar
  5. 5.
    Jackson, WPU (1955). Osteoporosis — commonest of all diseases. S Af Med J, 29, 885Google Scholar
  6. 6.
    National Institute of Health, 1984. Consensus conference: Osteoporosis. JAMA, 252, 799CrossRefGoogle Scholar
  7. 7.
    Recker, RR, Savile, PD and Heaney, RP (1977). Effect of oestrogens and calcium carbonate on bone loss in post-menopausal women. Ann Int Med, 87, 649PubMedGoogle Scholar
  8. 8.
    Horsman, A, Gallagher, JC, Simpson, M and Nordin, BEC (1977). Prospective trial of oestrogen and calcium in postmenpausal women. Brit Med J, 283, 789CrossRefGoogle Scholar
  9. 9.
    Nachtigall, LE, Nachtigall, RH, Nachtigall, RD and Beckman, EM (1979). Estrogen replacement therapy I: a 10 year prospective study in the relationship to osteoporosis. Obstet Gynecol, 53, 277PubMedGoogle Scholar
  10. 10.
    Bartley, MH, Arnold, JS, Haslam, RK and Webster, SSJ. The relationship of bone strength and bone quantity in health, disease and ageing. J Gerontol, 21, 517Google Scholar
  11. 11.
    Smith, DA, Anderson, JB, Shimmins, J, Spiers, CF and Barnett, E (1969). Changes in metacarpal mineral content and density in normal male and female subjects with age. Clin Radiol, 20, 23PubMedCrossRefGoogle Scholar
  12. 12.
    Mazess, RB, Barden HS, Ettinger, M, Johnston, C, Dawson-Hughes, B, Baran, D, Powell, M and Notelovitz, M (1987). Spine and femur density using dual photon absorptiometry in US white women. Bone Min, 2, 211Google Scholar
  13. 13.
    Aloia, JF, Cohn, SH, Vaswani, A, Yeh, JK, Yuen, K and Ellis, K (1985). Risk factors for post-menopausal osteoporosis. Am J Med, 78, 95PubMedCrossRefGoogle Scholar
  14. 14.
    Fogelman, I and Bessent, R (1982). Age related alterations in skeletal metabolism — 24 hour whole-body retention of diphosphonate in 250 normal subjects. J Nucl Med, 23, 296PubMedGoogle Scholar
  15. 15.
    Frost, HM (1963). Bone remodelling dynamics. Eds. Charles C. Thomas, Springfield II, IllinoisGoogle Scholar
  16. 16.
    Garn, S, Rohmann, CG, and Wagner, B (1967). Bone loss as a general phenomenon in man. Fed Proc, 26, 1729PubMedGoogle Scholar
  17. 17.
    Goldsmith, NF, Johnston, JO, Picetti, G and Garcia, C (1973). Bone mineral in the radius and vertebral osteoporosis in an insured population. J Bone Joint Surg, 55, 1276PubMedGoogle Scholar
  18. 18.
    Riggs, BL, Wahner, HW, Melton, LJ III, Richelson, LS, Judd, HL, and Offord, KP (1986). Rates of bone loss in the appendicular and axial skeletons of women: evidence of substantial vertebral loss before the menopause. J Clin Invest, 77, 1487PubMedCrossRefGoogle Scholar
  19. 19.
    Geusens, P, Dequeker, J, Verstraeten, A, and Nijs, J (1986). Age, sex and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med, 27, 1540PubMedGoogle Scholar
  20. 20.
    Christiansen, C, Christensen, MS, McNair, P, Hagan, C, Stocklund, E, and Transbol, IB (1980). Prevention of early postmenopausal bone loss: controlled 2 year study in 315 normal females. Eur J Clin Invest, 10, 273PubMedCrossRefGoogle Scholar
  21. 21.
    Crilly, RG, Jones, MM, Horsman, A and Nordin, BEC (1980). Rise in plasma alkaline phosphatase at the menopause. Clin Sci, 58, 341PubMedGoogle Scholar
  22. 22.
    Johnston, CC Jr, Norton, JA Jr, Khairi, RA and Longcope, C (1979). Age-related bone loss. In: Barzel, US (eds.). “Osteoporosis II”. p.91. (New York: Grune and Stratton)Google Scholar
  23. 23.
    Nordin, BEC and Polley, KJ (1987). Metabolic consequences of the menopause. A cross-sectional, longitudinal and intervention study on 557 normal post-menopausal women. Calcif Tiss Int, 41 (suppl), 1CrossRefGoogle Scholar
  24. 24.
    Riggs, BL, Wahner, HW, Dunn, WL, Mazess, RB and Offord, KP (1981). Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin Invest, 67, 328PubMedCrossRefGoogle Scholar
  25. 25.
    Johnston, CC Jr, Hui, SL, Witt, RM, Appledorn, R, Baker, RS and Longcope, C (1985). Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab, 61, 905PubMedCrossRefGoogle Scholar
  26. 26.
    Genant, HK, Cann, CE, Ettinger, MD, and Gordon, GS (1982). Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Int Med, 97, 699PubMedGoogle Scholar
  27. 27.
    Ruegsegger, LS and Dambacher, M (1983). Clinical application of peripheral computed tomography. Excerpta Med Int Congr Ser, 617, 48Google Scholar
  28. 28.
    Nilas, L, Borg, J, Gotfredsen, A and Christiansen, C (1985). Comparison of single and dual photon absorptiometry in post-menopausal bone mineral loss. J Nucl Med, 26, 1257PubMedGoogle Scholar
  29. 29.
    Gotfredsen, A, Nilas, L. Riis, B, Thomsen, K and Christiansen, C (1986). Bone changes occurring spontaneously and caused by oestrogen in early post-menopausal women: a local or generalised phenomenon? Brit Med J, 292, 1098CrossRefGoogle Scholar
  30. 30.
    Mazess, RB, Peppier, WW, Chesney, RW, Lange, TA, Lindgren, U and Smith, E Jr (1984) Does bone measurement on the radius indicate skeletal status? J Nucl Med, 25, 281PubMedGoogle Scholar
  31. 31.
    Reinbold, W-D, Genant, HK, Reiser, UJ, Harris, ST and Ettinger, B (1986). Bone mineral content in early post-menopausal and post-menopausal osteoproroic women. Radiology, 160, 469PubMedGoogle Scholar
  32. 32.
    Christiansen, C, Riis, BJ, and Rodbro, P (1987). Prediction of rapid bone loss in post-menopausal women. Lancet, 1, 1105PubMedCrossRefGoogle Scholar
  33. 33.
    Nordin, BEC and Need, AG (1987). How can we prevent osteoporosis? In: Christiansen, C, Johansen, JS and Riis, BJ (eds.). “Osteoporosis”, p.1204. (Denmark: Norhaven A/S)Google Scholar
  34. 34.
    Nordin, BEC, Need, AG, and Morris, HA (1987). More on bone mineral screening for osteoporosis. New Eng J Med, 317, 1538PubMedCrossRefGoogle Scholar
  35. 35.
    Krolner, B and Pors Nielsen, S (1982). Bone mineral content of the lumbar spine in normal and osteoporotic women: cross sectional and longitudinal studies. Clin Sci, 62, 329PubMedGoogle Scholar
  36. 36.
    Schlenker, RA and VonSeggen, WW (1976). The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and the implications for in vivo bone mass measurements. Calcif Tiss Res, 20, 41CrossRefGoogle Scholar
  37. 37.
    Krolner, B and Pors Neilson, S (1980). Measurement of bone mineral content of the lumbar spine, I: theory and application of a new two-dimensional dual photon attenuation method. Scand J Clin Lab Invest, 40, 653PubMedCrossRefGoogle Scholar
  38. 38.
    Rose, GA (1970). The irreversibility of osteoporosis. In: Barzel, US (ed.). “Osteoporosis”, p.123. (New York:Grune and Stratten)Google Scholar
  39. 39.
    Pocock, NA, Eisman, JA, Dunstan, CR, Evans, RA, Thomas, DH and Huq, NL (1987). Recovery from steroid-induced osteoporosis. Ann Int Med, 107, 319PubMedGoogle Scholar
  40. 40.
    Drolner, B, Jorgensen, JV, and Nielsen, SP (1983). Spinal bone mineral content in myxoedema and thyrotoxicosis. Effect of thyroid hormones and anti-thyroid treatment. Clin Endocrinol, 18, 439CrossRefGoogle Scholar
  41. 41.
    Treasure, JL, Russell, GFM, Fogelman, I and Murby, B (1987). Reversible bone loss in anorexia nervosa. Brit Med J, 295, 475CrossRefGoogle Scholar
  42. 42.
    Chesnut, CH III, Sisom, K, Nelp, WB, Gruber, HE, Ivey, JL, Matthews, M, and Baylink, DJ (1983). Are synthetic salmon calcitonin and anabolic steroids efficacious in the treatment of post-menopausal osteoporosis?. In: Dixon, A, StJ, Russell, RGG, and Stamp, TCB (eds.). “Osteoporosis: A multi-disciplinary problem”, p.139. (London: Academic Press)Google Scholar
  43. 43.
    Savvas, M, Montgomery, JC, Dooley, M, Fogelman, I and Studd, JWW (1987). A comparison of oestrogen and testosterone implants and oral oestrogen replacement therapy in the prevention of post-menopausal osteoporosis. In: Christiansen, C, Johansen, JS and Riis, BL (eds.) “Osteoporosis”, p.45. (Denmark: Norhaven A/S)Google Scholar
  44. 44.
    Riggs, BL, Seeman, E, Hodgson, SF, Raves, DL, and O’Fallon, WM (1982). Effect of the fluorine/calcium regime on vertebral fracture occurence in post-menopausal osteoporosis. New Eng J Med, 306. 446PubMedCrossRefGoogle Scholar
  45. 45.
    Fentiman, IS and Powells, TJ (1987). Tamoxifen and benign breast problems. Lancet, 2, 1070Google Scholar
  46. 46.
    Matta, WH and Shaw, RW (1987). Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in pre-menopausal women. Brit Med J, 129, 1523CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • I. Fogelman
    • 1
  • A. Rodin
    • 1
  1. 1.Departments of Nuclear Medicine and GynaecologyGuy’s HospitalLondonUK

Personalised recommendations